276 related articles for article (PubMed ID: 35003214)
21. Dissecting the Role of N6-Methylandenosine-Related Long Non-coding RNAs Signature in Prognosis and Immune Microenvironment of Breast Cancer.
Zhang J; Shan B; Lin L; Dong J; Sun Q; Zhou Q; Chen J; Han X
Front Cell Dev Biol; 2021; 9():711859. PubMed ID: 34692676
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the m6A-related lncRNA signature in predicting prognosis and immune response in patients with colon cancer.
Chen S; Li X; Guo L; Zhang J; Li L; Wang X; Zhu Y; Wang J
J BUON; 2021; 26(5):1931-1941. PubMed ID: 34761602
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Analysis of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Tumor Microenvironment of Bladder Cancer.
Chen K; Zhu S; Yu W; Xia Y; Xing J; Geng J; Cheng F
Front Oncol; 2022; 12():774307. PubMed ID: 35141159
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma.
Yu ZL; Zhu ZM
Bioengineered; 2021 Dec; 12(1):1708-1724. PubMed ID: 33955330
[TBL] [Abstract][Full Text] [Related]
26. Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer.
Zheng J; Guo J; Cao B; Zhou Y; Tong J
Cancer Cell Int; 2021 Jul; 21(1):363. PubMed ID: 34238292
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
28. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y
Front Oncol; 2022; 12():876660. PubMed ID: 35747790
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
[TBL] [Abstract][Full Text] [Related]
30. Identification of Five m6A-Related lncRNA Genes as Prognostic Markers for Endometrial Cancer Based on TCGA Database.
Shan L; Lu Y; Xiang CC; Zhu X; Zuo ED; Cheng X
J Immunol Res; 2022; 2022():2547029. PubMed ID: 35571565
[TBL] [Abstract][Full Text] [Related]
31. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
Xu M; Mu J; Wang J; Zhou Q; Wang J
Front Oncol; 2022; 12():961213. PubMed ID: 35965536
[TBL] [Abstract][Full Text] [Related]
32. Analysis and prognostic significance of tumour immune infiltrates and immune microenvironment of m6A-related lncRNAs in patients with gastric cancer.
Huang J; Song J; Li X; Liu S; Huang W; Shen Z; Cheng Y; Kou S; Gao Z; Tian Y; Hu J
BMC Med Genomics; 2022 Jul; 15(1):164. PubMed ID: 35879790
[TBL] [Abstract][Full Text] [Related]
33. Construction of a Novel Signature and Prediction of the Immune Landscape in Soft Tissue Sarcomas Based on N6-Methylandenosine-Related LncRNAs.
Zhang L; Tang X; Wan J; Zhang X; Zheng T; Lin Z; Liu T
Front Mol Biosci; 2021; 8():715764. PubMed ID: 34733885
[No Abstract] [Full Text] [Related]
34. m6A-related lncRNA-based immune infiltration characteristic analysis and prognostic model for colonic adenocarcinoma.
Wang HL; Ye ZM; He ZY; Huang L; Liu ZH
Hereditas; 2023 Feb; 160(1):6. PubMed ID: 36755298
[TBL] [Abstract][Full Text] [Related]
35. N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer.
Zhang Y; Zhu B; He M; Cai Y; Ying X; Jiang C; Ji W; Zeng J
Front Oncol; 2021; 11():710767. PubMed ID: 34458149
[TBL] [Abstract][Full Text] [Related]
36. A N6-methyladenosine-related long noncoding RNAs model for predicting prognosis in oral squamous cell carcinoma: Association with immune cell infiltration and tumor metastasis.
Yang Q; Cheng C; Zhu R; Guo F; Lai R; Liu X; Li M
Oral Oncol; 2022 Apr; 127():105771. PubMed ID: 35189585
[TBL] [Abstract][Full Text] [Related]
37. The prognostic value and immune landscapes of m1A/m5C/m6A-associated lncRNA signature in osteosarcoma.
Wu ZY; Shi ZY
Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5868-5883. PubMed ID: 36066162
[TBL] [Abstract][Full Text] [Related]
38. Integrated Analyses Reveal Potential Functional N6-Methyladenosine-Related Long Noncoding RNAs in Adrenocortical Adenocarcinoma.
Ding Y; Wang T; Feng Y; Ding X; Li X; Huang Z; Jia Z; Wang J; Yang J
Front Cell Dev Biol; 2022; 10():851748. PubMed ID: 35669515
[No Abstract] [Full Text] [Related]
39. Prognostic Value of Drug Targets Predicted Using Deep Bioinformatic Analysis of m6A-Associated lncRNA-Based Pancreatic Cancer Model Characteristics and Its Tumour Microenvironment.
Cao PW; Liu L; Li ZH; Cao F; Liu FB
Front Genet; 2022; 13():853471. PubMed ID: 35547245
[TBL] [Abstract][Full Text] [Related]
40. The Role of Critical N6-Methyladenosine-Related Long Non-Coding RNAs and Their Correlations with Immune Checkpoints in Renal Clear Cell Carcinoma.
Deng W; Wang G; Deng H; Yan Y; Zhu K; Chen R; Liu X; Chen L; Zeng T; Fu B
Int J Gen Med; 2021; 14():9773-9787. PubMed ID: 34934351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]